{
    "2020-10-13": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie (ABBV) Stock Moves -0.55%: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "stock moves",
                        "-0.55%"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Lilly's Mirikizumab Retains Efficacy in Crohn's Disease Study",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Mirikizumab",
                        "Crohn's Disease",
                        "efficacy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "NIH to test AbbVie, Boehringer Ingelheim drug in combination with remdesivr",
                "features": {
                    "keywords": [
                        "NIH",
                        "AbbVie",
                        "Boehringer Ingelheim",
                        "remdesivir",
                        "drug trial"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "research"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Coronavirus update: J&J and Eli Lilly trials hit pause as US doubles down on antibody therapies",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "J&J",
                        "Eli Lilly",
                        "trials paused",
                        "antibody therapies"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}